Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06624592

Sevoflurane/Dexmedetomidine vs. Isoflurane for Pediatric Emergence Delirium

Sevoflurane/Dexmedetomidine vs. Isoflurane and Their Effects on Pediatric Emergence Delirium

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
2 Years – 7 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to measure the incidences of pediatric emergence delirium between the group receiving Isoflurane and the group receiving Sevoflurane plus intravenous push dexmedetomidine.

Conditions

Interventions

TypeNameDescription
DRUGSevofluraneSubjects will receive standard of care anesthesia Sevoflurane, with intravenous push Dexmedetomidine
DRUGIsofluraneSubjects will receive standard of care anesthesia Isoflurane

Timeline

Start date
2024-12-20
Primary completion
2026-11-01
Completion
2026-11-01
First posted
2024-10-03
Last updated
2025-12-16

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06624592. Inclusion in this directory is not an endorsement.